Answers are grounded in this paper and cite their sources.
Background Intracerebral hemorrhage (ICH) is a devastating stroke subtype characterized by high mortality and long-term disability, yet the precise immunological mechanisms driving secondary brain injury remain incompletely understood. High-mobility group box 1 (HMGB1), a prototypical damage-associated molecular pattern (DAMP), has been implicated in various acute brain insults; however, the specific cascade by which microglia-derived HMGB1 orchestrates neutrophil homeostasis and amplifies neuroinflammation following ICH remains largely uncharacterized. Methods Here, we collected clinical plasma samples from ICH patients and established a collagenase-induced ICH rat model to recapitulate post-hemorrhagic neuroinflammation, combined with a Transwell co-culture system of microglia and neutrophils for in vitro mechanistic validation. We administered anti-HMGB1 neutralizing antibody to inhibit extracellular HMGB1 activity. HMGB1 expression levels were quantified by ELISA and Western blotting, while microglial activation markers (CD11b, CD45), inflammatory cytokines, neutrophil activation markers (CD15, CD66b), and B-cell regulatory factors (BAFF, APRIL) were systematically evaluated. Results We demonstrated that ICH patients exhibited markedly elevated plasma HMGB1 levels accompanied by increased pro-inflammatory mediators. Consistent with clinical findings, HMGB1 was robustly upregulated in the peri-hematomal brain tissues of ICH rats. In vivo, neutralization of HMGB1 significantly attenuated microglial activation and suppressed systemic neuroinflammatory responses. In vitro co-culture assays further verified that microglia promoted neutrophil activation, at least in part through HMGB1-mediated paracrine signaling, an effect effectively reversed by anti-HMGB1 treatment. Mechanistically, HMGB1 blockade abolished the synergistic upregulation of B-cell activating factors (BAFF and APRIL) and other immune-related proteins (MPO, CD25, CD69) induced by microglial-neutrophil crosstalk. Conclusions These findings identify extracellular HMGB1 as a candidate inflammatory target after ICH and support further preclinical evaluation of its effects on tissue injury and neurological outcomes.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: